Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177527 | SCV000229410 | benign | not specified | 2015-04-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002362906 | SCV002656380 | benign | Inborn genetic diseases | 2018-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002517712 | SCV003493642 | benign | not provided | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004552996 | SCV004761221 | likely benign | CHD8-related disorder | 2023-12-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |